Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled study of intravenous ibuprofen for moderate to severe postoperative pain
CTR20244287Phase 3Completed
- Sponsor
- 山东新华制药股份有限公司
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen in postoperative pain, sponsored by 山东新华制药股份有限公司. Started Nov 2024; status: completed.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20244287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244287.